Investment Analysts’ updated eps estimates for Thursday, November 2nd:

Acxiom Corporation (NASDAQ:ACXM) had its buy rating reaffirmed by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $35.00 target price on the stock.

Akebia Therapeutics (NASDAQ:AKBA) had its hold rating reiterated by analysts at Royal Bank Of Canada. They currently have a $17.00 price target on the stock.

Air Lease Corporation (NYSE:AL) had its buy rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $80.00 price target on the stock.

Alimera Sciences (NASDAQ:ALIM) had its buy rating reaffirmed by analysts at Cowen and Company. The analysts wrote, “Adaptimmune reported Q3 financials including net loss of $1MM and a cash balance.””

Allegion PLC (NYSE:ALLE) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Allegion’s third-quarter 2017 earnings were in line with the Zacks Consensus Estimate while revenues missed the consensus mark by 1.5%. Adjusted earnings were however up 9.7% from the prior-year quarter. Quarterly net revenues increased 4.9% on a year-over-year basis on the back of continued organic growth, synergies from acquisitions and favorable foreign currency impact. Revenues were also up 2.7% on an organic basis. Adjusted operating margin was up 30 basis points year over year owing to solid price performance, volume leverage and productivity, which offset impact from unfavorable product mix, increased investments and inflation. Adjusted EBITDA margin was however down 20 basis points. Moreover, global currency fluctuations are a major headwind.”

Alnylam Pharmaceuticals (NASDAQ:ALNY) had its overweight rating reissued by analysts at Piper Jaffray Companies. The firm currently has a $14.71 target price on the stock, down from their previous target price of $188.00.

Allison Transmission Holdings (NYSE:ALSN) had its buy rating reissued by analysts at Royal Bank Of Canada.

Amarin Corporation PLC (NASDAQ:AMRN) had its buy rating reissued by analysts at HC Wainwright. They currently have a $10.00 price target on the stock.

ANSYS (NASDAQ:ANSS) had its hold rating reissued by analysts at Evercore ISI. Evercore ISI currently has a $113.00 target price on the stock.

AveXis (NASDAQ:AVXS) had its hold rating reissued by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $92.00 target price on the stock.

BCE (NYSE:BCE) (TSE:BCE) had its hold rating reaffirmed by analysts at Canaccord Genuity. They currently have a $60.00 price target on the stock.

Brookfield Renewable Partners (TSE:BEP.UN) (NYSE:BEP) was downgraded by analysts at CIBC from an outperform rating to a neutral rating. The firm currently has C$45.00 target price on the stock.

bluebird bio (NASDAQ:BLUE) had its buy rating reiterated by analysts at Maxim Group. Maxim Group currently has a $170.00 price target on the stock.

Brocade Communications Systems (NASDAQ:BRCD) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. They currently have a $12.75 price target on the stock.

Brixmor Property Group (NYSE:BRX) had its hold rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $22.00 price target on the stock.

Baytex Energy Corp (NYSE:BTE) (TSE:BTE) had its buy rating reissued by analysts at Canaccord Genuity. They currently have a $4.25 target price on the stock.

Cavium (NASDAQ:CAVM) had its buy rating reissued by analysts at Loop Capital. The firm currently has a $81.00 target price on the stock.

Cavium (NASDAQ:CAVM) had its buy rating reaffirmed by analysts at Needham & Company LLC. Needham & Company LLC currently has a $78.00 price target on the stock.

Cogent Communications Holdings (NASDAQ:CCOI) was downgraded by analysts at Citigroup Inc. from a neutral rating to a sell rating.

Charter Communications (NASDAQ:CHTR) had its buy rating reissued by analysts at Royal Bank Of Canada. They currently have a $400.00 target price on the stock.

Colliers International Group (NASDAQ:CIGI) (TSE:CIGI) had its buy rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $66.00 price target on the stock.

Canadian Natural Resources Limited (NYSE:CNQ) (TSE:CNQ) had its buy rating reissued by analysts at Canaccord Genuity. They currently have a $48.00 target price on the stock.

Susquehanna Bancshares Inc started coverage on shares of Tapestry (NYSE:COH). The firm issued a positive rating and a $50.00 target price on the stock.

Tableau Software (NYSE:DATA) had its hold rating reiterated by analysts at Mizuho. Mizuho currently has a $68.00 price target on the stock. The analysts wrote, “We expect total revenue of $220-225mm (+7-9% Y/Y) vs. guidance of $213-223mm and consensus of $219mm. This includes license revenue of $105-110mm (down 6-10% Y/Y) vs. consensus of $106mm. For profitability, we expect operating income and EPS toward the upper-end of guidance of $5-13mm and $0.04-0.11, respectively, vs. consensus of $10mm and $0.09. Click here for our detailed preview and model. Checks suggest sustained focus on enterprise segment.””

Dynegy (NYSE:DYN) had its hold rating reissued by analysts at Royal Bank Of Canada. They currently have a $12.10 target price on the stock.

Brinker International (NYSE:EAT) had its buy rating reiterated by analysts at Maxim Group. They currently have a $49.00 target price on the stock.

The Wilder Hill Clean Energy Index (NYSE:ECO) had its buy rating reissued by analysts at Canaccord Genuity. The firm currently has a $3.00 price target on the stock.

NIC (NASDAQ:EGOV) had its hold rating reissued by analysts at Maxim Group. Maxim Group currently has a $16.00 target price on the stock.

Epizyme (NASDAQ:EPZM) had its buy rating reissued by analysts at HC Wainwright. They currently have a $25.00 target price on the stock.

Etsy (NASDAQ:ETSY) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. The analysts wrote, “We continue to rate Discovery Buy. Discovery Communications announced 3Q17 earnings featuring slightly better-than-expected results on revenues and adjusted OIBDA. Revenues were up +6%, including domestic revenues up by +4% and international revenues up +11%. Domestically, advertising was up +3%. This favorable outcome in what was likely a negative market during the quarter was led by favorable viewing trends for the company’s networks and aided by +1% from monetization of inventory on Discovery Go, the company’s TV Everywhere product. The exclusion of assets associated with Group 9 reduced advertising growth by +1%.””

Extra Space Storage (NYSE:EXR) had its hold rating reiterated by analysts at BMO Capital Markets. The firm currently has a $78.00 price target on the stock.

Fate Therapeutics (NASDAQ:FATE) had its buy rating reiterated by analysts at HC Wainwright.

Facebook (NASDAQ:FB) had its buy rating reaffirmed by analysts at Deutsche Bank AG.

FireEye (NASDAQ:FEYE) had its buy rating reaffirmed by analysts at Evercore ISI. The firm currently has a $20.00 price target on the stock.

Flowserve Corporation (NYSE:FLS) had its hold rating reiterated by analysts at Boenning Scattergood.

Generac Holdlings (NYSE:GNRC) had its hold rating reiterated by analysts at Canaccord Genuity. They currently have a $54.00 target price on the stock.

Groupon (NASDAQ:GRPN) had its buy rating reiterated by analysts at B. Riley. The firm currently has a $6.30 price target on the stock.

Hortonworks (NASDAQ:HDP) had its hold rating reaffirmed by analysts at Mizuho. They currently have a $14.00 target price on the stock. The analysts wrote, “We expect subscription revenue of $48-50mm (up 48-54% Y/Y), which compares with consensus of $47mm on continued uptake of solutions. Total revenues could print around $64-66mm (up 35-39% Y/Y) vs. consensus of $63mm. For profitability, we expect ongoing focus on execution to drive operating income toward the upper-end of guidance of a loss of $25-27mm (cons: loss of $26mm) while EPS could be in-line with to modestly better than consensus of ($0.40) as well. CFFO estimates could be slightly on the higher side. Click here for our detailed preview and model. Checks suggest continuation of recent trends. We think large deal activity could show meaningful acceleration Y/Y as execution improves and the market matures.””

Heron Therapeutics (NASDAQ:HRTX) had its buy rating reiterated by analysts at Cantor Fitzgerald. Cantor Fitzgerald currently has a $31.00 target price on the stock.

Histogenics Corporation (NASDAQ:HSGX) had its buy rating reissued by analysts at HC Wainwright. HC Wainwright currently has a $3.50 price target on the stock.

Imperial Oil (NYSEMKT:IMO) (TSE:IMO) had its hold rating reaffirmed by analysts at Canaccord Genuity. The firm currently has a $45.00 price target on the stock.

Imperial Oil (TSE:IMO) (NYSEMKT:IMO) was downgraded by analysts at Barclays PLC from an overweight rating to an underweight rating. Barclays PLC currently has C$38.00 price target on the stock, down from their previous price target of C$44.00.

iPass (NASDAQ:IPAS) had its buy rating reaffirmed by analysts at Maxim Group. Maxim Group currently has a $2.00 price target on the stock.

Juno Therapeutics (NASDAQ:JUNO) had its buy rating reaffirmed by analysts at Maxim Group. The firm currently has a $56.00 price target on the stock.

Coca-Cola Company (The) (NYSE:KO) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Coca-Cola reported better-than-expected third-quarter 2017 results. Lower SG&A expense (down 20%), higher gross margin (up 170 basis points or bps), and higher operating margin (up 404 bps) helped it come up with better numbers. Organic revenues were up 4%, driven by 3% growth in price/mix and concentrate sales growth of 1%. However, Coca-Cola's total sales decreased 15%, marking the 10th consecutive quarterly decline in revenues. Although top line needs to show sustained improvement, we are encouraged by the company’s strategic efforts in making its portfolio as a total beverage company with improved marketing and innovation, focus on driving revenues by improved price/mix, digital focus, and productivity initiatives toward driving margins. Further, solid performance of Coke Zero Sugar globally (growing high single digit) is quite encouraging.”

Lawson Products (NASDAQ:LAWS) had its outperform rating reaffirmed by analysts at Barrington Research. The firm currently has a $30.00 price target on the stock.

Leidos Holdings (NYSE:LDOS) had its buy rating reissued by analysts at Cowen and Company. They currently have a $68.00 price target on the stock.

Springleaf Holdings (NASDAQ:LEAF) had its buy rating reiterated by analysts at Canaccord Genuity. They currently have a $15.00 target price on the stock.

Macerich Company (The) (NYSE:MAC) had its buy rating reiterated by analysts at Royal Bank Of Canada. Royal Bank Of Canada currently has a $66.00 price target on the stock.

Mitel Networks Corporation (NASDAQ:MITL) (TSE:MNW) had its hold rating reiterated by analysts at Royal Bank Of Canada. They currently have a $8.50 price target on the stock.

Mallinckrodt PLC (NYSE:MNK) had its buy rating reiterated by analysts at Cantor Fitzgerald. They currently have a $52.00 price target on the stock.

NewAlliance Bancshares (NYSE:NAL) had its buy rating reaffirmed by analysts at Canaccord Genuity.

Neurocrine Biosciences (NASDAQ:NBIX) had its buy rating reiterated by analysts at Deutsche Bank AG. Deutsche Bank AG currently has a $79.00 target price on the stock.

NexPoint Residential Trust (NASDAQ:NXRT) had its buy rating reissued by analysts at Ladenburg Thalmann Financial Services.

ObsEva SA (NASDAQ:OBSV) had its buy rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $22.00 price target on the stock.

Omeros Corporation (NASDAQ:OMER) had its market perform rating reiterated by analysts at Cowen and Company.

Onconova Therapeutics (NASDAQ:ONTX) had its buy rating reissued by analysts at Maxim Group. The firm currently has a $6.00 price target on the stock.

Oshkosh Corporation (NYSE:OSK) had its buy rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $100.00 target price on the stock.

Perficient (NASDAQ:PRFT) had its buy rating reiterated by analysts at Maxim Group. Maxim Group currently has a $22.00 price target on the stock, up from their previous price target of $20.00. The analysts wrote, “3Q17 services revenue was $114 million, which was flat on an organic basis and in line with our estimate.””

Qorvo (NASDAQ:QRVO) had its buy rating reissued by analysts at Needham & Company LLC. The firm currently has a $84.00 target price on the stock.

Qorvo (NASDAQ:QRVO) had its buy rating reaffirmed by analysts at Drexel Hamilton. They currently have a $95.00 price target on the stock.

Q2 Holdings (NYSE:QTWO) was downgraded by analysts at Canaccord Genuity from a buy rating to a hold rating.

Sucampo Pharmaceuticals (NASDAQ:SCMP) had its buy rating reissued by analysts at Maxim Group. Maxim Group currently has a $23.00 target price on the stock.

Simon Property Group (NYSE:SPG) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $176.00 target price on the stock.

Summit Materials (NYSE:SUM) had its buy rating reissued by analysts at Royal Bank Of Canada.

Symantec Corporation (NASDAQ:SYMC) had its hold rating reiterated by analysts at Evercore ISI. They currently have a $25.00 target price on the stock.

Symantec Corporation (NASDAQ:SYMC) had its buy rating reiterated by analysts at Barclays PLC. Barclays PLC currently has a $36.00 price target on the stock.

Triangle Capital Corporation (NYSE:TCAP) was downgraded by analysts at Bank of America Corporation from a buy rating to an underperform rating.

Tesla (NASDAQ:TSLA) had its hold rating reiterated by analysts at Citigroup Inc.. They currently have a $371.00 price target on the stock.

U.S. Physical Therapy (NYSE:USPH) had its buy rating reissued by analysts at Cantor Fitzgerald. The firm currently has a $74.00 price target on the stock. The analysts wrote, “Storm impact contained, outlook fine. Hurricanes cost an estimated $0.03 per share in 3Q17, fully diluted EPS were $0.48 (vs. our $0.52 estimate), and we are reducing our full year 2017 estimate to $2.10 (from $2.15). We are raising our 2018 estimate to $2.45 (from $2.40). Our corresponding full year adjusted EBITDA estimates (3Q17 results were about $900,000 shy of our $14.6 million estimate) are $57.7 million for 2017 (vs. prior $58.6 million) and $65.5 million (vs. prior $63.7 million ) for 2018. Commercial reimbursement rates look fine for 2018; the average reimbursement for commercial is $100 vs. Medicare’s $90.””

Telefonica Brasil (NYSE:VIV) had its hold rating reaffirmed by analysts at Royal Bank Of Canada. The firm currently has a $15.60 target price on the stock.

Vmware (NYSE:VMW) had its buy rating reiterated by analysts at Drexel Hamilton. The firm currently has a $120.00 target price on the stock.

Voya Financial (NYSE:VOYA) had its buy rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $50.00 target price on the stock.

Verisk Analytics (NASDAQ:VRSK) had its hold rating reiterated by analysts at Royal Bank Of Canada. The firm currently has a $83.00 price target on the stock.

Wright Medical Group N.V. (NASDAQ:WMGI) had its buy rating reissued by analysts at Royal Bank Of Canada. The firm currently has a $30.00 price target on the stock.

Wright Medical Group N.V. (NASDAQ:WMGI) had its hold rating reissued by analysts at Needham & Company LLC.

Watts Water Technologies (NYSE:WTS) had its buy rating reaffirmed by analysts at Boenning Scattergood.

Acceleron Pharma (NASDAQ:XLRN) had its hold rating reiterated by analysts at Royal Bank Of Canada.

Yelp (NYSE:YELP) had its buy rating reissued by analysts at KeyCorp. The firm currently has a $54.00 price target on the stock.

Zoe’s Kitchen (NYSE:ZOES) had its buy rating reaffirmed by analysts at Maxim Group. Maxim Group currently has a $20.00 price target on the stock. The analysts wrote, “We reiterate our Buy rating and $20 price target on Zoe’s Kitchen (ZOES) ahead of the release of 3Q17 (September) results on Thursday, November 9. We lower our 3Q17 EPS estimate to $0.01, from $0.02, as we reduce our quarterly comp forecast to +0.8% (from +1.5%) to account for closures related to Hurricanes Harvey and Irma. We maintain our 2018 EPS estimate of $0.12 on a mix of positive comps and improved margins.””

Daiwa Capital Markets assumed coverage on shares of Zto Express (NYSE:ZTO). The firm issued a buy rating and a $18.50 price target on the stock.

Sleep Country Canada Holdings (TSE:ZZZ) was downgraded by analysts at TD Securities from a buy rating to a hold rating. They currently have C$41.00 price target on the stock, down from their previous price target of C$45.00.

Receive News & Ratings for Acxiom Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acxiom Corporation and related companies with MarketBeat.com's FREE daily email newsletter.